X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs LUPIN LTD - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD LUPIN LTD ALEMBIC LTD/
LUPIN LTD
 
P/E (TTM) x 76.1 17.0 448.8% View Chart
P/BV x 2.8 4.0 71.5% View Chart
Dividend Yield % 0.4 0.8 50.9%  

Financials

 ALEMBIC LTD   LUPIN LTD
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
LUPIN LTD
Mar-16
ALEMBIC LTD/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs532,127 2.5%   
Low Rs291,294 2.3%   
Sales per share (Unadj.) Rs4.7304.1 1.6%  
Earnings per share (Unadj.) Rs8.850.4 17.4%  
Cash flow per share (Unadj.) Rs9.060.7 14.8%  
Dividends per share (Unadj.) Rs0.157.50 2.0%  
Dividend yield (eoy) %0.40.4 83.3%  
Book value per share (Unadj.) Rs27.7243.8 11.4%  
Shares outstanding (eoy) m267.03450.58 59.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.75.6 154.6%   
Avg P/E ratio x4.733.9 13.8%  
P/CF ratio (eoy) x4.628.2 16.2%  
Price / Book Value ratio x1.57.0 21.1%  
Dividend payout %1.714.9 11.5%   
Avg Mkt Cap Rs m10,962770,740 1.4%   
No. of employees `000NA16.4 0.0%   
Total wages/salary Rs m23821,077 1.1%   
Avg. sales/employee Rs ThNM8,379.6-  
Avg. wages/employee Rs ThNM1,289.0-  
Avg. net profit/employee Rs ThNM1,388.7-  
INCOME DATA
Net Sales Rs m1,260137,016 0.9%  
Other income Rs m2641,877 14.1%   
Total revenues Rs m1,524138,893 1.1%   
Gross profit Rs m8337,535 0.2%  
Depreciation Rs m614,635 1.3%   
Interest Rs m0446 0.1%   
Profit before tax Rs m28534,330 0.8%   
Minority Interest Rs m0-88 0.0%   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m611,536 0.1%   
Profit after tax Rs m2,34322,707 10.3%  
Gross profit margin %6.627.4 24.0%  
Effective tax rate %2.133.6 6.4%   
Net profit margin %185.916.6 1,121.7%  
BALANCE SHEET DATA
Current assets Rs m1,68997,790 1.7%   
Current liabilities Rs m48653,872 0.9%   
Net working cap to sales %95.432.1 297.7%  
Current ratio x3.51.8 191.4%  
Inventory Days Days21785 256.2%  
Debtors Days Days81121 66.9%  
Net fixed assets Rs m1,62486,379 1.9%   
Share capital Rs m534901 59.3%   
"Free" reserves Rs m5,960105,735 5.6%   
Net worth Rs m7,404109,844 6.7%   
Long term debt Rs m10453,739 0.2%   
Total assets Rs m8,010224,378 3.6%  
Interest coverage x950.777.9 1,219.8%   
Debt to equity ratio x00.5 2.9%  
Sales to assets ratio x0.20.6 25.8%   
Return on assets %29.310.3 283.5%  
Return on equity %31.620.7 153.1%  
Return on capital %31.321.2 147.5%  
Exports to sales %2.949.1 6.0%   
Imports to sales %28.97.4 387.7%   
Exports (fob) Rs m3767,244 0.1%   
Imports (cif) Rs m36410,199 3.6%   
Fx inflow Rs m3771,405 0.1%   
Fx outflow Rs m36517,807 2.0%   
Net fx Rs m-32853,598 -0.6%   
CASH FLOW
From Operations Rs m346-3,690 -9.4%  
From Investments Rs m-48-69,434 0.1%  
From Financial Activity Rs m-30158,126 -0.5%  
Net Cashflow Rs m-3-14,998 0.0%  

Share Holding

Indian Promoters % 64.0 46.6 137.3%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.2 11.3 1.8%  
FIIs % 9.7 31.9 30.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 10.1 258.4%  
Shareholders   54,701 98,259 55.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  SANOFI INDIA  DR. DATSONS LABS  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Pharma Drug Approvals, Global Updates, Oil Prices, and Top Stocks in Action Today(Pre-Open)

Indian share markets snapped their losing streak seen during last week and closed their Wednesday session on a positive note.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Lupin: Key Products Drive US growth (Quarterly Results Update - Detailed)

Sep 12, 2016

Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 16, 2017 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - SUVEN LIFE COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS